RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Hudson Bay Capital Management LP's Holding History (CIK: 0001393825)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 425,000 Value ($000) $1,738 Avg Close $4.95 Range $3.81 - $7.18
Q3 2025
Shares 225,000 Value ($000) $1,098 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 150,000 Value ($000) $759 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 127,070 Value ($000) $672 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 77,500 Value ($000) $524 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 90,000 Value ($000) $593 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 45,000 Value ($000) $338 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 30,000 Value ($000) $299 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 80,000 Value ($000) $789 Avg Close $7.13 Range $4.97 - $11.17
Q3 2023
Shares 40,000 Value ($000) $306 Avg Close $9.98 Range $6.44 - $16.75
Q2 2023
Shares 110,000 Value ($000) $822 Avg Close $7.00 Range $4.54 - $10.45
Q2 2022
Shares 120,000 Value ($000) $977 Avg Close $6.69 Range $4.92 - $9.40
Q1 2022
Shares 200,000 Value ($000) $1,432 Avg Close $10.63 Range $5.80 - $18.23